|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2008-2-21
|
|
pubmed:abstractText |
The pathogenesis of hepatitis C virus (HCV)-associated glucose intolerance remains unclear. Glucagon-like peptide-1 (GLP-1), a gut hormone, synthesizes hepatic glycogen and is inactivated by dipeptidyl peptidase IV (DPPIV). The aims of this study were to investigate the alterations in the expression of GLP-1 and DPPIV in HCV-associated glucose intolerance.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1440-1746
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
23
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
244-51
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:17944883-Adult,
pubmed-meshheading:17944883-Dipeptidyl Peptidase 4,
pubmed-meshheading:17944883-Fasting,
pubmed-meshheading:17944883-Glucagon-Like Peptide 1,
pubmed-meshheading:17944883-Glucose,
pubmed-meshheading:17944883-Glucose Intolerance,
pubmed-meshheading:17944883-Glycogen,
pubmed-meshheading:17944883-Hepatitis B,
pubmed-meshheading:17944883-Hepatitis C,
pubmed-meshheading:17944883-Humans,
pubmed-meshheading:17944883-Ileum,
pubmed-meshheading:17944883-Immunoblotting,
pubmed-meshheading:17944883-Immunohistochemistry,
pubmed-meshheading:17944883-Inflammatory Bowel Diseases,
pubmed-meshheading:17944883-Insulin,
pubmed-meshheading:17944883-Liver,
pubmed-meshheading:17944883-Middle Aged
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Altered expression of glucagon-like peptide-1 and dipeptidyl peptidase IV in patients with HCV-related glucose intolerance.
|
|
pubmed:affiliation |
Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
